What Does It Cost to Start a Hormone Therapy Business?

The cost to start a hormone clinic is not a single national number. The real budget starts with compliance decisions: whether you will run any lab testing, whether HIPAA-covered telehealth tools are involved, whether controlled-substance rules apply, and whether your marketing needs legal review. Those choices create upfront and recurring costs before you ever count staff, rent, or local taxes.

Start with the cost buckets you can actually verify

For founders, the fastest way to think about a hormone therapy business budget is to separate fixed compliance obligations from ordinary operating expenses. Federal sources give you a clear view of several recurring costs, but they do not provide a universal price tag for staffing, malpractice, software bundles, or revenue potential.

That means the launch question is less “What does it cost?” and more “Which regulatory layers will apply to my model?” If you are still mapping the business model, the framework in How to Start a TRT and Hormone Therapy Business is a useful companion to this cost guide.

The core budget categories that move the number

Here is a founder-friendly way to organize the TRT clinic startup cost or broader hormone practice budget.

CLIA is one of the most concrete startup cost drivers

If your practice performs even one diagnostic or treatment-related lab test on human-derived material, CMS says a laboratory may be subject to CLIA. That matters because blood draws and specimen collection alone are not the same as running a lab.

For budgeting, CLIA is not just an enrollment step; it can become a recurring expense. CMS’s current fee schedule shows a $123 registration fee, a $248 biennial waived certificate fee, and a $297 biennial provider-performed microscopy certificate fee. For nonwaived labs, fees scale with test volume, and the schedule also shows average survey fees that vary by certificate type and volume.

If your model includes onsite testing, specimen processing, or any workflow that might cross into laboratory activity, review What Is Telehealth Licensing and Who Needs It? alongside your lab plan. The licensing question and the lab question are related, but they are not identical.

A second CLIA cost issue is timing. CMS says compliance and accreditation laboratories are surveyed every two years and may owe compliance survey, validation survey, revisit, and follow-up fees. CMS also says the average State Agency hourly rate cited in the 2024 materials is $111.81 per hour for certain onsite follow-up and complaint survey activity.

One more operational detail matters for founders: CMS says CLIA administration is now paperless, and fee payment is online. That does not change the need to budget for the fees themselves, but it does affect how you plan internal admin work and accounts payable.

HIPAA is not a checkbox; it is a cost line

If your hormone therapy business uses telehealth platforms, remote intake, e-signatures, messaging, or video visits, HIPAA is part of your operating budget. HHS says covered health care providers and health plans must comply with HIPAA Rules and must use vendors that comply with HIPAA, with business associate agreements in place for telehealth video or remote communication technologies.

That means founders should budget for more than the software subscription. HIPAA-related launch costs can include:

• vendor review and business associate agreement negotiation
• privacy and security policies
• workforce training
• access controls and device security
• breach response planning
• risk analysis and documentation

HHS also states that covered entities must have a written business associate contract or other arrangement with vendors handling PHI, and business associates are directly liable for certain HIPAA provisions. In practical terms, the telehealth platform is part of your infrastructure budget, not just your tech stack.

This is where a white-label infrastructure provider such as MDLaunchr and WhiteLabelClinic.com can be one option to evaluate. The brand is not a clinician or regulator, and it does not replace legal review, but it can help qualified businesses assess the technology and operational pieces that sit around a compliance-first launch. If you are in pricing mode, the next step is straightforward: See pricing.

Controlled-substance rules can change the workflow and the price

Not every hormone practice involves controlled substances, but many founders want to know the cost picture if testosterone is part of the model. DEA identifies testosterone as a Schedule III example, and DEA/HHS telemedicine flexibilities have been extended through December 31, 2026.

That does not give a founder a blanket shortcut. It does mean the budget should reflect the fact that controlled-substance handling can add process burden, documentation, compliance review, and ongoing rule monitoring. If controlled medications are in scope, the question is not only “Can we prescribe?” but also “What does our workflow require to do this responsibly and lawfully in the states we serve?”

For a broader view of business-model structure, the guide on Corporate Practice of Medicine Explained for Founders helps explain why ownership, control, and clinical decision-making are separate issues from branding and technology.

Advertising review is a real startup expense

FTC guidance makes one thing clear: health-related claims get close scrutiny. That means the budget for a hormone therapy business should include review of website copy, landing pages, testimonials, ad creative, and any performance or outcome claims.

This is especially important in a market where founders may be tempted to market the business as if it were a results machine. It is better to budget for claim substantiation and compliance review early than to treat advertising as a free channel and legal cleanup as an afterthought.

That expense can sit inside internal review, outside counsel, or a compliance workflow built into your launch process. Either way, it is part of the true cost to start a hormone clinic.

A simple launch-cost decision framework

Use this checklist to estimate where your budget pressure will come from:

• Will you run any lab tests onsite? If yes, CLIA may apply and recurring fee obligations are likely.
• Will your care model use telehealth tools that handle PHI? If yes, HIPAA vendor and policy work belongs in the budget.
• Will testosterone or another controlled substance be in scope? If yes, controlled-substance compliance and rule monitoring can add cost.
• Will your marketing mention outcomes, symptoms, or patient experiences? If yes, you need claims review.
• Will you serve patients in more than one state? If yes, state licensing and telehealth rules may materially change the cost structure.

That fifth point is not a minor detail. HHS says telehealth licensure requirements vary at the federal, state, and cross-state levels, and state Medicaid coverage also varies. If you need a state-aware launch plan, the next step is not to guess; it is to review state-by-state requirements before you finalize your budget.

What federal sources do not let you price

Federal guidance gives founders a reliable framework, but not a final national price. It does not give you a single number for:

• staffing
• rent or physical buildout
• malpractice coverage
• local taxes
• pharmacy or fulfillment contracts
• billing platform pricing
• revenue or patient volume

That is why two hormone businesses can look similar from the outside and have very different launch costs underneath. A telehealth-only consult model will not carry the same budget as a hybrid practice with onsite testing, controlled-substance workflows, and state-specific requirements.

If you are evaluating infrastructure instead of building every piece from scratch, MDLaunchr and WhiteLabelClinic.com are designed to help qualified businesses assess the technology, operational, compliance, clinical-network, and fulfillment relationships involved in launching telehealth services. That does not eliminate your responsibility to verify state rules, but it can help you compare platform options in a more structured way.

Bottom line for founders

The cost to start a hormone clinic is driven by compliance design first and operations second. The biggest federally verifiable cost centers are CLIA, HIPAA, controlled-substance compliance, and advertising review. State law can add more, especially when licensing, telehealth, or laboratory rules differ across jurisdictions.

So the best early budget is not a guess. It is a checklist-based estimate that separates what you can confirm now from what still needs state and counsel review.

FAQ

Do I need CLIA if I only collect blood and send it out?

CMS says blood draws and specimen collection alone are not laboratories. CLIA becomes relevant if you perform even one diagnostic or treatment-related lab test on human-derived material.

What recurring federal costs should I expect first?

The clearest recurring federal costs in a hormone practice budget are CLIA certificate and survey fees, HIPAA compliance work for telehealth tools, controlled-substance compliance if applicable, and advertising review.

Is testosterone always part of a hormone therapy business?

No. Business models vary. But if testosterone is in scope, DEA identifies it as a Schedule III example, which is why controlled-substance compliance should be reviewed early.

Can I build the brand before I sort out compliance?

You can define the brand, but you should not finalize marketing claims, workflow, or vendor contracts before you understand state licensing, HIPAA, CLIA, and any controlled-substance implications.

How does telehealth change the startup budget?

Telehealth usually shifts spending toward software, privacy/security controls, BAAs, documentation, and workflow design. It may reduce some physical overhead, but it does not remove compliance costs.

Where should I start if I want a pricing conversation?

Start with the launch model first, then compare infrastructure options. If you are evaluating a compliance-first telehealth launch, See pricing to review how the platform side may fit your budget and workflow.

Disclaimer

This article is for general educational purposes only and is not legal, regulatory, tax, or medical advice. Federal and state requirements can change, and your actual startup costs depend on your business model, state footprint, clinical scope, and vendor choices. Have qualified legal, clinical, and compliance professionals review your specific launch before you proceed.